瑞财经 刘治颖近日,厦门为正生物科技股份有限公司(以下简称:为正生物)披露关于向不特定合格投资者公开发行股票并在北京证券交易所上市辅导工作进展情况报告(第十三期),兴业证券为辅导机构。据瑞财社查阅,为正生物于2022年5月19日启动IPO辅导。本期辅导自2025年4月1日至本报告出具日。为正生物成立于2013年7月,专业从事快速诊断试剂及配套仪器的研发、制造、营销及服务,是国家级高新技术企业,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.